Tumor-derived KLK5 activates TMEM158(+) cancer-associated fibroblasts to induce CD8(+) T cell exhaustion and confer immunotherapy resistance in lung cancer.
- DOI
- 10.1016/j.drup.2026.101473
- Published
- 2026 Aug 25
- Container
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drup.2026.101473,
title = {Tumor-derived KLK5 activates TMEM158(+) cancer-associated fibroblasts to induce CD8(+) T cell exhaustion and confer immunotherapy resistance in lung cancer.},
author = {Pu S and Li G and Jiang Y and Shao C and Hou X and You L and Yu P and Jiang T and Zhao Y and Liu T and Lu Y and Wang D and Du R and Li C and Zhang J and Sun G and Gao Y},
year = {2026},
journal = {Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy},
doi = {10.1016/j.drup.2026.101473},
url = {https://doi.org/10.1016/j.drup.2026.101473}
}RIS
TY - JOUR TI - Tumor-derived KLK5 activates TMEM158(+) cancer-associated fibroblasts to induce CD8(+) T cell exhaustion and confer immunotherapy resistance in lung cancer. AU - Pu S AU - Li G AU - Jiang Y AU - Shao C AU - Hou X AU - You L AU - Yu P AU - Jiang T AU - Zhao Y AU - Liu T AU - Lu Y AU - Wang D AU - Du R AU - Li C AU - Zhang J AU - Sun G AU - Gao Y PY - 2026 JO - Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy DO - 10.1016/j.drup.2026.101473 UR - https://doi.org/10.1016/j.drup.2026.101473 ER -
APA
S, P., G, L., Y, J., C, S., X, H., L, Y., P, Y., T, J., Y, Z., T, L., Y, L., D, W., R, D., C, L., J, Z., G, S., & Y, G. (2026). Tumor-derived KLK5 activates TMEM158(+) cancer-associated fibroblasts to induce CD8(+) T cell exhaustion and confer immunotherapy resistance in lung cancer.. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. https://doi.org/10.1016/j.drup.2026.101473
Source records
- pubmed · retrieved 2026-09-25T13:10:19.689Z